tiprankstipranks
Australian Dairy Nutritionals Group (AU:AHF)
ASX:AHF
Want to see AU:AHF full AI Analyst Report?

Australian Dairy Nutritionals Group (AHF) AI Stock Analysis

9 Followers

Top Page

AU:AHF

Australian Dairy Nutritionals Group

(Sydney:AHF)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 5.2)
Rating:41Neutral
Price Target:
AU$0.01
▼(-65.00% Downside)
Action:Reiterated
Date:06/23/26
The score is held down primarily by weak financial performance—loss-making operations (negative margins) and cash flow challenges—despite strong recent revenue growth and very low leverage. Technicals further pressure the score with a clear downtrend and negative momentum. Valuation is constrained by negative earnings (negative P/E) and the absence of a dividend yield.
Positive Factors
Revenue Growth
Sustained revenue growth of ~34.7% indicates continued market demand and successful top-line expansion. Over 2-6 months this growth can provide scale benefits, support fixed-cost absorption and create a pathway to margin recovery if unit economics improve and cost structure is managed.
Negative Factors
Negative Profitability
Persistently negative margins show core operations are not yet profitable, undermining the sustainability of growth. Without structural margin improvement—through pricing, mix, or cost reductions—continued losses will erode equity and constrain the firm's ability to reinvest and scale profitably over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained revenue growth of ~34.7% indicates continued market demand and successful top-line expansion. Over 2-6 months this growth can provide scale benefits, support fixed-cost absorption and create a pathway to margin recovery if unit economics improve and cost structure is managed.
Read all positive factors

Australian Dairy Nutritionals Group (AHF) vs. iShares MSCI Australia ETF (EWA)

Australian Dairy Nutritionals Group Business Overview & Revenue Model

Company Description
Australian Dairy Nutritionals Group operates as a fully integrated enterprise specializing in the production of dairy products throughout Australia. The company's activities are organized into two main divisions: Dairy Farms and Dairy Processing. ...
How the Company Makes Money
null...

Australian Dairy Nutritionals Group Financial Statement Overview

Summary
Revenue growth is strong (+34.74%), but profitability is a major weakness with negative gross, EBIT/EBITDA, and net margins. Balance sheet leverage is very low (debt-to-equity 0.002), yet returns remain negative (negative ROE). Cash flow quality is pressured by negative free cash flow growth and negative operating cash flow to net income, indicating ongoing funding/liquidity strain despite free cash flow to net income slightly above 1.
Income Statement
35
Negative
Balance Sheet
45
Neutral
Cash Flow
30
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue7.53M7.17M6.18M5.86M5.80M21.30M
Gross Profit-1.10M-1.42M-2.15M-288.23K-4.36M-3.27M
EBITDA-4.54M-4.30M-6.26M-5.95M-1.29M-5.34M
Net Income-4.42M-5.21M-7.36M-9.16M-4.15M-6.40M
Balance Sheet
Total Assets24.17M25.09M30.35M36.24M44.60M43.11M
Cash, Cash Equivalents and Short-Term Investments809.01K2.69M6.13M2.01M2.43M6.23M
Total Debt200.85K48.45K2.25M1.04M1.09M6.49M
Total Liabilities2.02M1.44M3.62M2.72M4.65M9.12M
Stockholders Equity22.31M23.85M26.87M33.59M16.05M33.99M
Cash Flow
Free Cash Flow-3.65M-3.46M-4.72M-7.91M-6.90M-7.11M
Operating Cash Flow-3.24M-3.28M-4.44M-7.05M-3.80M-2.03M
Investing Cash Flow-245.46K-47.59K6.73M6.18M3.10M1.07M
Financing Cash Flow-184.50K-94.51K1.80M449.98K-3.07M796.49K

Australian Dairy Nutritionals Group Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.04
Price Trends
50DMA
0.02
Negative
100DMA
0.02
Negative
200DMA
0.03
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
19.66
Positive
STOCH
30.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AHF, the sentiment is Negative. The current price of 0.04 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and above the 200-day MA of 0.03, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 19.66 is Positive, neither overbought nor oversold. The STOCH value of 30.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:AHF.

Australian Dairy Nutritionals Group Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
AU$146.96M16.7312.22%2.19%27.60%96.31%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
58
Neutral
AU$74.21M19.058.70%23.29%
51
Neutral
AU$1.73B278.750.82%1.95%1.47%-76.20%
44
Neutral
AU$7.33M-0.01226.76%-32.83%83.37%
43
Neutral
AU$18.82M-3.27-41.69%53.69%45.24%
41
Neutral
AU$11.81M-2.50-19.17%44.25%41.58%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:AHF
Australian Dairy Nutritionals Group
0.02
-0.03
-65.91%
AU:BGA
Bega Cheese Limited
5.55
0.16
2.95%
AU:BUB
Bubs Australia Ltd.
0.08
-0.08
-49.38%
AU:NUC
Nuchev Pty Ltd
0.10
-0.06
-37.50%
AU:NGS
Nutritional Growth Solutions Ltd.
0.02
>-0.01
-4.35%
AU:CLV
Clover Corporation Limited
0.89
0.36
69.20%

Australian Dairy Nutritionals Group Corporate Events

Australian Dairy Nutritionals Fast-Tracks Amended Long-Term Incentive Plan
Jun 16, 2026
Australian Dairy Nutritionals Limited has approved an amended Long Term Incentive Plan aimed at providing structured equity incentives to eligible participants and aligning their interests with shareholders. The plan is designed to support the com...
Australian Dairy Nutritionals Targets China-Led Growth After Mixed Quarter
Apr 30, 2026
Australian Dairy Nutritionals reported third-quarter FY26 revenue of $1.4 million, down 13% on the prior corresponding period due to lower milk and livestock sales following its exit from the North Brucknell farm lease, while nutritional powder sa...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 23, 2026